actinomycin-D

This page contains recent news articles, when available, and an overview of actinomycin-D but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Pediatric cancer patient checks in at age 55; beneficiary of Dr ...  -  ‎Jun 30, 2009‎
Most of you scientific youngsters today probably only know of actinomycin D as a laboratory tool for inhibiting RNA synthesis. But here in the following ScienceBlogs

Activation of estrogen receptor beta-dependent nitric oxide ...  -  ‎Jul 7, 2009‎
...(1 pmol) were abolished by co-injection of ER antagonist ICI 182780 (0.25 or 0.5 pmol), but not a transcription inhibitor actinomycin D (10 nmol). 7thSpace Interactive (press release)

Molt-inhibiting hormone stimulates vitellogenesis at advanced ...  -  ‎Jul 7, 2009‎
Actinomycin D blocked the stimulatory effects of MIH in stage 3 animals on VtG mRNA and VtG, while cycloheximide attenuated only VtG levels, confirming the 7thSpace Interactive (press release)

09年执业西�?�师�?�物化  -  ‎Apr 16, 2009‎
...�?�类�?�物还有放线�?�素D（Actinomycin D），�?�称更生霉素，分�?中有�?��?嗪结构和两个多肽链。阿霉素（Adriamycin，多柔比星）与柔红霉素（Daunorubicin）是蒽醌类青年人

Proteomics: Insider information  -  Jan 9, 2009
...but the authors noted that these proteins displayed similar dynamics in response to the transcription inhibitor actinomycin D, leading them to propose Nature.com (subscription),

Pourquoi la cancérologie piétine  -  Jan 19, 2009
Effect of actinomycin D on estrogen-induced changes in enzymes and nucleic acids of R 3230 AC mammary tumors, uteri, and mammary glands. Cancer Res. Votre Santé,

Regulation of T cell receptor CD3 zeta chain expression by L-arginine  -  20 Oct 2008
Furthermore, the effect of L-Arg starvation in the CD3 z mRNA stability was Actinomycin-D sensible. In conclusion, the concentration of L-Arg in the Cancer Focus,

Spectrum Pharmaceuticals Presents Data on Lucanthone, a Novel ...  -  Apr 17, 2008
Lucanthone has structural and biochemical similarities to Actinomycin D but has no hematological or GI toxicity at clinically tolerated doses. Business Wire (press release),

Retrospective analysis of 105 cases with uterine sarcoma  -  Apr 5, 2008
Despite two other trials reporting better survival rates with a vincristine, actinomycin-D and cyclophosphamide (VAC) regimen, there exist trials reporting Bulletin du Cancer (Abonnement),

Vanishing Bone Disease: Review and Case Reports  -  10 Mar 2008
Therapeutic treatment with estrogens, magnesium, calcium, vitamin D and vitamin B12, fluoride, and calcitonin as well as cisplatin, actinomycin D, Ortho SuperSite,

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.